108 related articles for article (PubMed ID: 19492341)
1. Thermodynamic stability assessment of a colloidal iron drug product: sodium ferric gluconate.
Yang Y; Shah RB; Faustino PJ; Raw A; Yu LX; Khan MA
J Pharm Sci; 2010 Jan; 99(1):142-53. PubMed ID: 19492341
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical characterization and thermodynamic stability assessment of a colloidal iron drug product: iron sucrose.
Shah RB; Yang Y; Khan MA; Raw A; Yu LX; Faustino PJ
Int J Pharm; 2014 Apr; 464(1-2):46-52. PubMed ID: 24440404
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate.
Brandis JEP; Kihn KC; Taraban MB; Schnorr J; Confer AM; Batelu S; Sun D; Rodriguez JD; Jiang W; Goldberg DP; Langguth P; Stemmler TL; Yu YB; Kane MA; Polli JE; Michel SLJ
Mol Pharm; 2021 Apr; 18(4):1544-1557. PubMed ID: 33621099
[TBL] [Abstract][Full Text] [Related]
4. Short-term stability of a new generic sodium ferric gluconate in complex with sucrose.
Baribeault D
Curr Med Res Opin; 2011 Dec; 27(12):2241-3. PubMed ID: 21992082
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical Characterization of Iron Carbohydrate Colloid Drug Products.
Zou P; Tyner K; Raw A; Lee S
AAPS J; 2017 Sep; 19(5):1359-1376. PubMed ID: 28762128
[TBL] [Abstract][Full Text] [Related]
6. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
Pai AB; Boyd AV; McQuade CR; Harford A; Norenberg JP; Zager PG
Pharmacotherapy; 2007 Mar; 27(3):343-50. PubMed ID: 17316146
[TBL] [Abstract][Full Text] [Related]
7. Molecular weight determination for colloidal iron by Taguchi optimized validated gel permeation chromatography.
Shah RB; Yang Y; Khan MA; Faustino PJ
Int J Pharm; 2008 Apr; 353(1-2):21-7. PubMed ID: 18226479
[TBL] [Abstract][Full Text] [Related]
8. Update on adverse drug events associated with parenteral iron.
Chertow GM; Mason PD; Vaage-Nilsen O; Ahlmén J
Nephrol Dial Transplant; 2006 Feb; 21(2):378-82. PubMed ID: 16286429
[TBL] [Abstract][Full Text] [Related]
9. Iron management: innovative solutions to persistent challenges--focus on Ferrlecit.
Vogel S; Schweitzer S; Seiler S
ANNA J; 1999 Oct; 26(5):515-21. PubMed ID: 10776080
[TBL] [Abstract][Full Text] [Related]
10. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
Psathas PA; Kuzmission A; Ikeda K; Yasuo S
Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
[TBL] [Abstract][Full Text] [Related]
11. Influence of natural organic matter and ionic composition on the kinetics and structure of hematite colloid aggregation: implications to iron depletion in estuaries.
Mylon SE; Chen KL; Elimelech M
Langmuir; 2004 Oct; 20(21):9000-6. PubMed ID: 15461479
[TBL] [Abstract][Full Text] [Related]
12. Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: Physicochemical Characterization.
Sun D; Rouse R; Patel V; Wu Y; Zheng J; Karmakar A; Patri AK; Chitranshi P; Keire D; Ma J; Jiang W
Nanomaterials (Basel); 2018 Jan; 8(1):. PubMed ID: 29303999
[TBL] [Abstract][Full Text] [Related]
13. Single-dosage pharmacokinetics of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients.
Warady BA; Seligman PA; Dahl NV
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1140-6. PubMed ID: 17942782
[TBL] [Abstract][Full Text] [Related]
14. Colloidal stability of iron oxide nanoparticles with multivalent polymer surfactants.
Choi YW; Lee H; Song Y; Sohn D
J Colloid Interface Sci; 2015 Apr; 443():8-12. PubMed ID: 25526296
[TBL] [Abstract][Full Text] [Related]
15. Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients.
Shah RB; Bryant A; Collier J; Habib MJ; Khan MA
Int J Pharm; 2008 Aug; 360(1-2):77-82. PubMed ID: 18524511
[TBL] [Abstract][Full Text] [Related]
16. Long-term stability study of Prussian blue-A quality assessment of water content and cyanide release.
Mohammad A; Yang Y; Khan MA; Faustino PJ
Clin Toxicol (Phila); 2015 Feb; 53(2):102-7. PubMed ID: 25608705
[TBL] [Abstract][Full Text] [Related]
17. Weekly administration of high-dose sodium ferric gluconate is safe and effective in peritoneal dialysis patients.
Javier AM
Nephrol Nurs J; 2002 Apr; 29(2):183-6. PubMed ID: 11997953
[TBL] [Abstract][Full Text] [Related]
18. Stability indicating method for sodium montelukast in pharmaceutical preparations by micellar electrokinetic capillary chromatography.
Roman J; Malesuik MD; Jablonski A; Steppe M
Pharmazie; 2010 Sep; 65(9):645-9. PubMed ID: 21038840
[TBL] [Abstract][Full Text] [Related]
19. Solid phase extraction-spectrophotometric determination of salicylic acid using magnetic iron oxide nanoparticles as extractor.
Parham H; Rahbar N
J Pharm Biomed Anal; 2009 Aug; 50(1):58-63. PubMed ID: 19406599
[TBL] [Abstract][Full Text] [Related]
20. Sodium ferric gluconate causes oxidative stress but not acute renal injury in patients with chronic kidney disease: a pilot study.
Leehey DJ; Palubiak DJ; Chebrolu S; Agarwal R
Nephrol Dial Transplant; 2005 Jan; 20(1):135-40. PubMed ID: 15522899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
